期刊文献+

类风湿性关节炎患者IL-15、TNF-α的水平变化及意义 被引量:1

Change of IL-15,TNF-α levels in patients with rheumatoid arthritis and its clinical significance
原文传递
导出
摘要 目的:研究类风湿性关节炎(RA)患者血清IL-15、TNF-α的变化及其临床意义。方法:收集34例RA患者,以20例骨关节炎(OA)患者和30例健康体检者作对照。采用双抗体夹心酶联免疫吸附法测定血清IL-15、TNF-α的水平,并测定类风湿因子和C反应蛋白。结果:RA患者的血清IL-15、TNF-α的含量明显高于OA组及健康体检组(P<0.05),RA患者的类风湿因子明显高于对照组(P<0.05),C反应蛋白的含量在各组间差异无统计学意义;RA组中,血清IL-15、TNF-α水平明显相关(r=0.771)。结论:IL-15、TNF-α在RA患者的疾病发展过程中发挥着重要作用,阻断其生物活性,为靶向治疗RA患者提供了新思路。 Objective:To investigate the change of interleukin-15 and tumor necrosis factor-α levels in patients with rheumatoid arthritis(RA) and their clinical significance.Methods:34 patients with rheumatoid arthritis(RA group),20 patients with osteoarthritis(OA) and 30 healthy subjects(served as two control groups) were enrolled in the investigation.IL-15 and TNF-α levels were detected by double antibodies sandwich enzyme-linked immunosorbent assay(ELISA).The levels of rheumatoid factor and C-reactive protein were detected as well.Results:The level of IL-15,TNF-α and rheumatoid factor in RA patients were significantly higher than those in two control groups.In contract,the level of C-reactive protein in three groups showed no significant difference.The level of serum IL-15 significantly correlated with that of TNF-α in patients with RA(r=0.771).Conclusion:IL-15,TNF-α play an important role in the development of rheumatoid arthritis.Blocking the effects may give a new hope in treatment of RA.
出处 《中国卫生检验杂志》 CAS 2009年第12期2873-2874,共2页 Chinese Journal of Health Laboratory Technology
关键词 类风湿性关节炎 白细胞介素-15 肿瘤坏死因子-Α 类风湿因子 C反应蛋白 Rheumatoid arthritis Interleukin-15 Tumor necrosis factor-α Rheumatoid factor C-reactive protein
  • 相关文献

参考文献10

  • 1Choy EH, Panayi CS. Cytokine pathway and joint inflammation in rheumatoid arthritis [ J ]. N Engl J Med, 2001, 344 (12) :907 -916.
  • 2Cvetkovic JT, Wallberg- Jonsson S, Stegmayr B, et al. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF - α, IL - 1 Band IL - 1 Ra genes[ J]. J Rheumatol,2002,29(2) :212 -219.
  • 3高俊,丁真奇.细胞因子在类风湿性关节炎中作用的研究现状[J].医学综述,2006,12(5):289-291. 被引量:43
  • 4Groh V, Bruhl A, E1 - Gabalawy H, et al. Stimulation of T cell autore- activity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis[ J]. Proc Natl Acad Sci USA, 2003,100 (16) : 9452 - 9457.
  • 5Marks - Konzalik J, Dubois S, Losi JM, et al. IL - 2 induced activation -induced cell death is inhibited in IL - 15 trabsgenic mice[ J]. Proc Natl Acad Sci USA,2000,97 : 111445 -11450.
  • 6Dalbeth N, Gndle R, Davies RJ, et al. CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation[J]. J Immunol, 2004, 173:6418 -6426.
  • 7Miranda - Cams ME, Benito - Miguel M, Balsa A, et al. Peripheral blood T lymphocytes from patients with rheumatoid arthritis express RANKL and interleukin 15 on the cell surface and promote osteoclastogensis in autologous mouocytes [ J ]. Arthritis Rheum, 2006,54 : 1151 -1164.
  • 8Ribbens C, Franchimont N, Desoroux A, et al. Cell contact between IL - 15 activated T lymphocytes and fibroblasts induces the production of matrix metalloproteinasea [ J ]. Arthritis Rheum, 2000,43:90 - 94.
  • 9Min SY, Hwang SY, Jung YO, et al. Increase of cyclooxygenase -2 expression by interleukin 15 in rheumatoid synoviocytes [ J ]. J Rheumatol, 2004,3!(5) :875 - 883.
  • 10Taylor PC. Anti - cytokines and cytokines in the treatment of rheumatoid arthritis[J].Cult Pharm Dis, 2003, 9 (14) : 1095 - 1106.

二级参考文献19

  • 1Vuoheenaho K, Moilanen T, Hamalainen M, et al. Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage, Role of endegonous IL- 1 inhibitors [ J ]. Scand J Rheumatol, 2003,32 ( 1 ) : 19-24.
  • 2Yamamura M, Kawashima M, Taniai M, et al. Interferon-T-inducing activity of interleukin-18 in the joint rheumatoid arthritis [ J ]. Arthritis Rheum, 2001,44 ( 2 ) : 275 -285.
  • 3Leung BP,Mc Inncs IB,Esfandiari E, et al. Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis[J]. J Immunol, 2000,164 ( 12 ) : 6495 -6502.
  • 4Dinarello CA. Interleukin-18 and the treatment of rheumatoid arthritis[J]. Rheum Dis Clin North Am,2004,30(2):417-434.
  • 5Park CC, Morel JC, Amin MA, et al. Evidence of IL-18 as a novel angiogenic mediator[J] .J Immunol,2001,167(3) : 1644-1653.
  • 6Moore KW,de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor [J]. Annu Rev Immunol, 2001, 19: 683-765.
  • 7Min SY, Hwang SY, Park KS, et al, Induction of IL-10-producing CD4^+ CD25^+ T cells in animal model of collagen-induced arthritis by oral administration of type Ⅱ collagen[J]. Arthritis Res Ther, 2004,6( 3 ) :R213-219.
  • 8Szekanecz Z, Haines GK, Har LA, et al. Increased synovial expression of transforming growth factor (TGF)-βreceptor endoglin and TGF-βin rheumatoid arthritis possible interactions in the pathogenesis of the desease[J] . Clin Immunol Immunopathol, 1995,7(2) : 187.
  • 9Zuoning H, Boyle DL, Shi Y, et al. Dominant negative p53 mutations in rheumatoid arthritis[J]. Arthritis Rheum, 1999,42(6) : 1088-1092.
  • 10Redich KP,Hayen S,Ricct R, et al. Ostecolasts are essential for INF-mediated joint destruction[J]. Arthritis Res, 2002,4[ Suppl ] : S45-S47.

共引文献42

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部